Lixte Biotechnology Holdings Inc —— 财务报表 (NASDAQ:LIXT) | MetaTrader

展开完整图表

新闻

LIXTE Biotechnology appoints Sidney Braun to lead Liora subsidiary

LIXTE expands clinical trial for ovarian cancer treatment

Lixte生物科技在430万美元直接发行后股价下跌

斯巴达资本担任Lixte 430万美元融资的配售代理

Lixte Biotechnology stock falls after $4.3 million direct offering

Spartan Capital acts as placement agent in Lixte’s $4.3 million offering

Lixte生物科技股价在430万美元直接融资后下跌

Lixte Biotechnology stock falls after $4.3 million direct offering

Lixte Biotechnology raises $4.3 million in registered direct offering

Lixte生物科技股东批准董事会提名人选和股票计划修订案

Lixte Biotechnology shareholders approve board nominees and stock plan amendment

Lixte生物科技股价在收购英国Liora后下跌